Miglitol

This classification denotes a glucosidase inhibitor with the molecular formula C8H17NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 0V5436JAQW, chemically known as 3,4,5-piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2r-(2alpha,3beta,4alpha,5beta))- but more generally known as miglitol, which bears US NIH Compound Identifier 51577. European Medicines Agency schedules Miglitol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08958MIG. The term MIGLITOL is an International Non-Proprietary Name WHO schedules miglitol in its Anatomical Therapeutic Chemical (ATC) Classification. MIGLITOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule miglitol under HS 29333999 and SITC 51574. As of Q4 2014, MIGLITOL remains US FDA's Preferred Term for this commodity. Miglitol bears US NLM identifiers UMLS ID C0066535 and NCI Concept Code C61847. SMILES: OC1C(N(CC(O)C1O)CCO)CO.